Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports
New York, New York (PRWEB) December 24, 2014 -- The federal court overseeing Xarelto lawsuits (http://www.xareltolawsuit2015.com/) that allege the blood thinner caused life-threatening episodes of internal bleeding and other complications has outlined a leadership structure for the proceeding, Bernstein Liebhard LLP reports. According to an Order dated December 17th, the Court plans to select lawyers to serve as Liaison Counsel for the parties and also plans on appointing a Plaintiffs’ Steering Committee, which will coordinate the discovery stage of the litigation with the defendants’ representatives or committees. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is actively filing Xarelto lawsuits in federal court on behalf of individuals who were allegedly harmed by this blood thinner. We are monitoring this litigation closely, and are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free, no-obligation Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.
Xarelto Lawsuit Allegations
The Xarelto litigation was established less than a month ago, via a Transfer Order issued by the U.S. Judicial Panel on Multidistrict Litigation on December 12th. As such, all Xarelto lawsuits now pending in federal courts, as well as those filed in the future will be transferred to the Eastern District of Louisiana for coordinated pretrial proceedings. This type of multidistrict litigation is established when a large number of lawsuits that put forth similar questions of fact are expected to be filed. Such proceedings are designed to conserve the resources of the court, parties and witnesses by avoiding duplicative discovery and inconsistent rulings across the docket.
According to court documents, all of the Xarelto lawsuits pending in the Eastern District of Louisiana similarly accuse the drug’s manufacturers of failing to provide adequate warnings about its risks. Among other things, plaintiffs charge that Xarelto was wrongfully promoted as a superior alternative to warfarin, a blood thinner that has been in use for decades. They point out that while there is currently no approved antidote to reverse Xarelto bleeding, hemorrhaging associated with warfarin can be stopped via the administration of Vitamin K. The lawsuits also contend that Xarelto patients would benefit from regular blood monitoring, despite marketing claims that such testing is not necessary.
Alleged victims of Xarelto bleeding and other complications may be entitled to compensation for their injury related damages. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLPs website, or call 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.xareltolawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author
Felecia L. Stern, Xarelto Lawsuit Claims Center, http://www.xareltolawsuit2015.com/, +1 800-511-5092, [email protected]
Share this article